Malden, MA, United States of America

Alexandre Likhanskii

This inventor holds 46 USPTO granted patents and 11 published patent applications, primarily in Ion Beam Technology. Top assignees: Applied Materials, Inc., Varian Semiconductor Equipment Associates, Inc.. Active years: 2016-2026.

USPTO Granted Patents = 46 

% Patents Active = 97.8

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • Malden, MA (US) (2016 - 2023)
  • Middleton, MA (US) (2023)

Company Filing History:


Years Active: 2016-2026

Loading Chart...
Areas of Expertise:
Ion Beam Extraction
Mass Analyzed Ion Beam
Electrostatic Filter
Plasma Source Control
High-Current Ion Implanter
Uniformity Control
Conductive Beam Optics
Electrodynamic Mass Analysis
In-Situ Plasma Cleaning
Variable Thickness Electrode
Mismatched Optics
High Brightness Ion Beam
46 patents (USPTO):Explore Patents

Title: Inventor Profile - Alexandre Likhanskii

Introduction: Alexandre Likhanskii is a renowned inventor based in Malden, MA (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Alexandre Likhanskii holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his expertise in cutting-edge technologies.

Career Highlights: With a career spanning over two decades, Alexandre Likhanskii has worked with leading tech companies, research institutions, and universities, playing a pivotal role in developing advanced solutions for complex challenges.

Collaborations: Throughout his career, Alexandre Likhanskii has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and pushing the boundaries of technological advancements.

Conclusion: Alexandre Likhanskii's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…